pindolol has been researched along with Experimental Neoplasms in 3 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Excerpt | Relevance | Reference |
---|---|---|
"The interactions of agonists and antagonists with beta-adrenergic receptors on intact 1321N1 human astrocytoma and C62B rat glioma cells were studied by using the radioligand (-)-[125I]iodopindolol." | 3.66 | High-affinity binding of agonists to beta-adrenergic receptors on intact cells. ( Harden, TK; Perkins, JP; Toews, ML, 1983) |
" The widespread and chronic use of these drugs has generated a concern for their potential chronic toxicity." | 2.37 | A toxicological review of beta-adrenergic blockers. ( Fishbein, L; Jackson, CD, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Toews, ML | 1 |
Harden, TK | 1 |
Perkins, JP | 1 |
Johnson, GL | 1 |
Bourne, HR | 1 |
Gleason, MK | 1 |
Coffino, P | 1 |
Insel, PA | 1 |
Melmon, KL | 1 |
Jackson, CD | 1 |
Fishbein, L | 1 |
1 review available for pindolol and Experimental Neoplasms
Article | Year |
---|---|
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolami | 1986 |
2 other studies available for pindolol and Experimental Neoplasms
Article | Year |
---|---|
High-affinity binding of agonists to beta-adrenergic receptors on intact cells.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Astrocytoma; Binding, Competitive; C | 1983 |
Isolation and characterization of S49 lymphoma cells deficient in beta-adrenergic receptors: relation of receptor number to activation of adenylate cyclase.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Clone Cells; Enzyme Activation; Isoproterenol; Lymphoma | 1979 |